Mar 5, 2009 - GTx, Inc., today announced that the USFDAwill target a Prescription Drug User Fee Act agency action date of October 30, 2009 for the toremifene 80 mg New Drug Application (NDA), which is within 10 months of the submission of the NDA.
The details can be read here.
No comments:
Post a Comment